Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?

Mieke A. van der Mescht, Helen C. Steel, Ronald Anderson, Theresa M. Rossouw · 2025

Read Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections? by Mieke A. van der Mescht, Helen C. Steel, Ronald Anderson, Theresa M. Rossouw (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11850333.txt.

Description

Mieke van der Mescht and co-authors weigh in a review dated 2024 whether a vessel growth factor is friend or foe in HIV and COVID-19. VEGF-A drives blood vessel growth and upkeep, and both HIV and the COVID-19 virus batter the vessel lining. The review first sketches vessel balance and growth, then the triangle of low oxygen, this factor, and inflammation.

For COVID-19, the virus's grip on two cell receptors lifts VEGF-A, feeding clotting, leaky vessels, and inflammation. HIV attacks differently: its tat protein mimics the factor at its main receptor and boosts a partner receptor. Together in co-infection, the authors propose, immune cells pour out the factor after vessel damage switches on a low oxygen sensor. Trials of blocking the factor eased oxygen needs in COVID-19 care. Yet blocking both its receptors could backfire, and the review ends on that caution.

Catalog record

CREATORMieke A. van der Mescht, Helen C. Steel, Ronald Anderson, Theresa M. Rossouw
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE97 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11850333

Browse the full library · About the Tower of Babel